SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875320-13-000045
Filing Date
2013-11-07
Accepted
2013-11-07 16:22:30
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2013q310-q.htm 10-Q 1404719
2 EX-31.1 a2013q210-q_exhibit3112.htm EX-31.1 14547
3 EX-31.2 a2013q210-q_exhibit3122.htm EX-31.2 14381
4 EX-32.1 a2013q210-q_exhibit3212.htm EX-32.1 11782
  Complete submission text file 0000875320-13-000045.txt   8970414

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrtx-20130930.xml EX-101.INS 1469961
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrtx-20130930.xsd EX-101.SCH 56586
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrtx-20130930_cal.xml EX-101.CAL 80037
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrtx-20130930_def.xml EX-101.DEF 199508
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrtx-20130930_lab.xml EX-101.LAB 664516
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrtx-20130930_pre.xml EX-101.PRE 353626
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 131200936
SIC: 2834 Pharmaceutical Preparations